Log In
Print
BCIQ
Print
Print this Print this
 

NI-0401

  Manage Alerts
Collapse Summary General Information
Company Novimmune S.A.
DescriptionHuman mAb targeting CD3
Molecular Target CD3
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today